Gavilimomab
Modify Date: 2024-04-06 18:30:09
Gavilimomab structure
|
Common Name | Gavilimomab | ||
|---|---|---|---|---|
| CAS Number | 244096-20-6 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GavilimomabGavilimomab (ABX-CBL) is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease (GVHD)[1]. |
| Name | Gavilimomab |
|---|
| Description | Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease (GVHD)[1]. |
|---|---|
| Related Catalog | |
| Target |
CD147[1] |
| References |
| No Any Chemical & Physical Properties |